Unbound MEDLINE

Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study. Neurology [Neurology] Journal article

 
Edwards MJ, Trikouli E, Martino D, Bozi M, Dale RC, Church AJ, Schrag A, Lees AJ, Quinn NP, Giovannoni G, Bhatia KP 
Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study. [Journal Article, Research Support, Non-U.S. Gov't ]
Neurology 2004 Jul 13; 63(1):156-8.


Anti-basal ganglia antibodies (ABGA) are associated with movement disorders in children, but have not been assessed in adult onset movement disorders. In a prospective assessment ABGA were positive in 65% of a group of 65 patients with atypical movement disorders, but were very rare in healthy adults and adults with idiopathic dystonia. An autoimmune mechanism may underlie a proportion of cases of atypical movement disorders.



More from this journalRelated subjects (MeSH)
  
Advertise on this site.